Insider Shareholders with Direct Ownership of Emergent Bio Solutions Inc. (EBS)
This section provides a comprehensive overview of the insiders with direct ownership of Emergent Bio Solutions Inc. (EBS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Emergent BioSolutions Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Fuad El Hibri
Director |
79,391 | 79,391 | 1,123,988 $10.2 Million | 8 |
Nov 10, 2020
Reduced 1.7%
|
|
Robert Kramer
President and CEO |
485,744 | 118,895 | 506,059 $4.58 Million | 27 |
Jun 09, 2023
Added 21.86%
|
|
Jennifer Lynne Fox
EVP, Ext Aff, GC, Corp Sec |
188,866 | 9,734 | 186,382 $1.69 Million | 14 |
Jul 11, 2024
Added 7.45%
|
|
Adam Havey
EVP, Business Operations |
191,670 | 49,957 | 174,398 $1.58 Million | 20 |
Jun 09, 2023
Added 22.01%
|
|
Richard S Lindahl
EVP, Chief Financial Officer |
171,097 | 31,894 | 171,009 $1.55 Million | 26 |
Oct 15, 2024
Added 8.06%
|
|
Coleen Glessner
EVP, Quality & Ethics, and CPL |
166,309 | 2,215 | 163,134 $1.48 Million | 8 |
Jun 08, 2024
Reduced 0.76%
|
|
Donald W De Golyer
Director |
136,100 | 0 | 136,100 $1.23 Million | 2 |
May 23, 2024
Added 11.35%
|
|
Neal Franklin Fowler
Director |
136,100 | 0 | 136,100 $1.23 Million | 2 |
May 23, 2024
Added 11.35%
|
|
Louis W Sullivan
Director |
75,055 | 3,118 | 104,695 $948,536 | 6 |
May 23, 2024
Added 14.27%
|
|
Zsolt Harsanyi
Chairman |
64,750 | 0 | 89,329 $809,320 | 4 |
May 23, 2024
Added 16.33%
|
|
Atul Saran
EVP, Chief Strat & Dev Officer |
60,408 | 13,259 | 86,645 $785,003 | 16 |
Feb 28, 2023
Reduced 1.11%
|
|
Ronald Richard
Director |
64,750 | 1,912 | 71,114 $644,292 | 5 |
May 23, 2024
Added 19.69%
|
|
Marvin L White
Director |
68,379 | 0 | 68,379 $619,513 | 5 |
May 23, 2024
Added 20.31%
|
|
Sujata Tyagi Dayal
Director |
63,129 | 0 | 63,129 $571,948 | 3 |
May 23, 2024
Added 21.64%
|
|
Katherine Strei
EVP, Chief HR Officer |
44,931 | 10,116 | 62,824 $569,185 | 16 |
Feb 28, 2023
Reduced 1.09%
|
|
Keith Katkin
Director |
59,872 | 0 | 59,872 $542,440 | 3 |
May 23, 2024
Added 22.55%
|
|
Jerome M Hauer
Director |
47,320 | 0 | 57,508 $521,022 | 3 |
May 25, 2023
Added 37.05%
|
|
Kathryn C Zoon
Director |
64,750 | 22,757 | 54,482 $493,606 | 12 |
Jun 04, 2024
Reduced 15.51%
|
|
William Hartzel
SVP, Bioservices |
15,000 | 2,810 | 48,107 $435,849 | 5 |
Jul 11, 2024
Added 23.77%
|
|
George A Joulwan
Director |
13,473 | 0 | 40,244 $364,610 | 2 |
May 26, 2022
Added 17.35%
|
|
Sue Bailey
Director |
0 | 8,168 | 24,427 $221,308 | 1 |
Mar 04, 2021
Reduced 25.06%
|
|
Paul Anthony Williams
SVP, Products Business |
17,309 | 2,352 | 24,333 $220,456 | 11 |
Jul 08, 2024
Reduced 0.35%
|
|
Sean Kirk
EVP, Manufacturing & Tech Ops |
6,418 | 1,213 | 17,776 $161,050 | 4 |
Mar 31, 2021
Reduced 0.89%
|
|
Karen L. Smith
EVP, Chief Medical Officer |
5,883 | 305 | 11,888 $107,705 | 2 |
May 07, 2021
Reduced 2.5%
|